Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye-Jee Kim

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Plos One|May 21, 2015
Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort studyJong-Mi Seong, Nam-Kyong Choi, Ju-Young Shin, et al.
Journal of Korean Medical Science|February 10, 2026
Trends in Atypical Antipsychotic Use Among Children and Adolescents With Depressive Disorders in KoreaKee Jeong Park, Ye-Jee Kim, Eunji Jung, et al.
Metabolism: Clinical and Experimental|May 10, 2019
Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort studyYun Kyung Cho, Yu Mi Kang, Jee Hee Yoo, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2023
Stratification of Nontuberculous Mycobacterial Disease Risk in Type 2 Diabetes Based on Metformin Use: a Population-Based Cohort Study in South KoreaHyeon Hwa Kim, Seonok Kim, Mi Ae Kim, et al.
Open Forum Infectious Diseases|November 25, 2020
Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019Seongman Bae, Ju Hyeon Kim, Ye-Jee Kim, et al.
Microbiology Spectrum|March 28, 2023
Type 2 Diabetes Mellitus- and Complication-Related Risk of Nontuberculous Mycobacterial Disease in a South Korean CohortDa Som Jeon, Seonok Kim, Mi Ae Kim, et al.
BMC Geriatrics|January 23, 2024
Comparison of anticholinergic burden with chronic polypharmacy on functional decline and mortality in Korean older people: a retrospective nationwide cohort studyYoun Huh, Ye-Jee Kim, Jung-Yeon Choi, et al.
The Journal of Dermatological Treatment|February 25, 2024
Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in KoreaHyesoo Cho, Ye-Jee Kim, Ik Jun Moon, et al.
The American Journal of Cardiology|July 9, 2022
Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial FibrillationChang Hee Kwon, Ye-Jee Kim, Min-Ju Kim, et al.
Frontiers in Oncology|February 12, 2024
Detection and evaluation of signals for immune-related adverse events: a nationwide, population-based studyEo Jin Kim, Ye-Jee Kim, Ja Yoon Heo, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Plos One|May 21, 2015
Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort studyJong-Mi Seong, Nam-Kyong Choi, Ju-Young Shin, et al.
Journal of Korean Medical Science|February 10, 2026
Trends in Atypical Antipsychotic Use Among Children and Adolescents With Depressive Disorders in KoreaKee Jeong Park, Ye-Jee Kim, Eunji Jung, et al.
Metabolism: Clinical and Experimental|May 10, 2019
Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort studyYun Kyung Cho, Yu Mi Kang, Jee Hee Yoo, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2023
Stratification of Nontuberculous Mycobacterial Disease Risk in Type 2 Diabetes Based on Metformin Use: a Population-Based Cohort Study in South KoreaHyeon Hwa Kim, Seonok Kim, Mi Ae Kim, et al.
Open Forum Infectious Diseases|November 25, 2020
Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019Seongman Bae, Ju Hyeon Kim, Ye-Jee Kim, et al.
Microbiology Spectrum|March 28, 2023
Type 2 Diabetes Mellitus- and Complication-Related Risk of Nontuberculous Mycobacterial Disease in a South Korean CohortDa Som Jeon, Seonok Kim, Mi Ae Kim, et al.
BMC Geriatrics|January 23, 2024
Comparison of anticholinergic burden with chronic polypharmacy on functional decline and mortality in Korean older people: a retrospective nationwide cohort studyYoun Huh, Ye-Jee Kim, Jung-Yeon Choi, et al.
The Journal of Dermatological Treatment|February 25, 2024
Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in KoreaHyesoo Cho, Ye-Jee Kim, Ik Jun Moon, et al.
The American Journal of Cardiology|July 9, 2022
Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial FibrillationChang Hee Kwon, Ye-Jee Kim, Min-Ju Kim, et al.
Frontiers in Oncology|February 12, 2024
Detection and evaluation of signals for immune-related adverse events: a nationwide, population-based studyEo Jin Kim, Ye-Jee Kim, Ja Yoon Heo, et al.
Pageof 16